Internationaler Name: NitroMed, Inc., Lexington, Massachusetts, United States
Marke / Handelsname: NitroMed
Registrierungsland: United States
Adresse: Massachusetts
Gründungsjahr: 1987
Beschreibung:
Former US pharmaceutical company (1987-2009) that developed BiDil, the first FDA-approved race-specific drug, for congestive heart failure; ceased operations in 2009.
Bewertung & Kommentar hinterlassen